{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:12:21Z","timestamp":1792001541958,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with diabetic ketoacidosis (DKA), a potentially fatal complication of type 1 diabetes, have hyperglycemia, ketonemia and metabolic acidosis. Blood glucose and blood ketone results are often used to triage patients with suspected DKA. This study aimed to establish how effective blood glucose and blood ketone (beta-hydroxybutyrate, BOHB) measurements are in identifying patients with significant acidosis and sought to validate existing diagnostic BOHB thresholds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Initial Emergency Department results on 161 presumptive DKA episodes in 95 patients (42\u00a0F, 53\u00a0M, age range 14\u201389 years) containing a complete dataset of D (glucose), K (BOHB) and A (Bicarbonate [HCO\n                      <jats:sub>3<\/jats:sub>\n                      ] and pH) results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Blood glucose correlated poorly with BOHB (r\u2009=\u20090.28 p\u2009=\u20090.0003), pH (r= -0.25, p\u2009=\u20090.002) and HCO\n                      <jats:sub>3<\/jats:sub>\n                      (r= -0.17, p\u2009=\u20090.04). BOHB, though better, was still limited in predicting pH (r = -0.44, p\u2009&lt;\u20090.0001) and HCO\n                      <jats:sub>3<\/jats:sub>\n                      (r = -0.49, p\u2009&lt;\u20090.0001). A HCO\n                      <jats:sub>3<\/jats:sub>\n                      of 18mmol\/L equated to a BOHB concentration of 4.3mmol\/L, whilst a HCO\n                      <jats:sub>3<\/jats:sub>\n                      of 15mmol\/L equated to a BOHB of 4.7mmol\/L. Of the 133 of 161 events with HCO\n                      <jats:sub>3<\/jats:sub>\n                      \u2009&lt;\u200918mmol\/L, 22 were not hyperglycemic (&gt;\u200913.9mmol\/L, n\u2009=\u20098), ketonemic (\u2264\u20093mmol\/L, n\u2009=\u20099) or either (n\u2009=\u20095).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The commonly employed BOHB diagnostic cutoff of 3mmol\/L could not be verified. Since acid-base status was poorly predicted by both glucose and BOHB, this highlights that, regardless of their results, pH and\/or HCO\n                      <jats:sub>3<\/jats:sub>\n                      should also be tested in any patient suspected of DKA.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-023-01176-w","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T23:23:34Z","timestamp":1697153014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The effectiveness of blood glucose and blood ketone measurement in identifying significant acidosis in diabetic ketoacidosis patients"],"prefix":"10.1186","volume":"15","author":[{"given":"Eric S.","family":"Kilpatrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naji","family":"Alamuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Atkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"issue":"7","key":"1176_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2337\/dc09-9032","volume":"32","author":"AE Kitabchi","year":"2009","unstructured":"Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335\u201343.","journal-title":"Diabetes Care"},{"issue":"2","key":"1176_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2337\/dc21-2279","volume":"45","author":"ES Kilpatrick","year":"2022","unstructured":"Kilpatrick ES, Butler AE, Ostlundh L, Atkin SL, Sacks DB. Controversies around the measurement of blood Ketones to diagnose and manage Diabetic Ketoacidosis. Diabetes Care. 2022;45(2):267\u201372.","journal-title":"Diabetes Care"},{"key":"1176_CR3","volume-title":"The management of Diabetic ketoacidosis in adults. London, UK: Joint British Diabetes Societies for Inpatient Care","author":"K Dhatariya","year":"2021","unstructured":"Dhatariya K. The management of Diabetic ketoacidosis in adults. London, UK: Joint British Diabetes Societies for Inpatient Care. Contract No.: JBDS 02; 2021."},{"issue":"Suppl 27","key":"1176_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/pedi.12701","volume":"19","author":"JI Wolfsdorf","year":"2018","unstructured":"Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19(Suppl 27):155\u201377.","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"1176_CR5","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.2337\/dc15-1380","volume":"38","author":"J Rosenstock","year":"2015","unstructured":"Rosenstock J, Ferrannini E. Euglycemic Diabetic Ketoacidosis: a predictable, detectable, and Preventable Safety concern with SGLT2 inhibitors. Diabetes Care. 2015;38(9):1638\u201342.","journal-title":"Diabetes Care"},{"issue":"12","key":"1176_CR6","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.2337\/dc17-1624","volume":"40","author":"G Agiostratidou","year":"2017","unstructured":"Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman KN, et al. Standardizing clinically meaningful outcome measures beyond HbA(1c) for type 1 diabetes: a Consensus Report of the American Association of Clinical Endocrinologists, the American Association of diabetes educators, the american Diabetes Association, the Endocrine Society, JDRF International, the Leona M. and Harry B. Helmsley charitable trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care. 2017;40(12):1622\u201330.","journal-title":"Diabetes Care"},{"issue":"8","key":"1176_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1046\/j.1464-5491.2001.00550.x","volume":"18","author":"TM Wallace","year":"2001","unstructured":"Wallace TM, Meston NM, Gardner SG, Matthews DR. The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice. Diabet Med. 2001;18(8):640\u20135.","journal-title":"Diabet Med"},{"issue":"4","key":"1176_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2337\/dc07-1683","volume":"31","author":"M Sheikh-Ali","year":"2008","unstructured":"Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, et al. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008;31(4):643\u20137.","journal-title":"Diabetes Care"},{"issue":"4","key":"1176_CR9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s13340-022-00581-2","volume":"13","author":"T Hirobata","year":"2022","unstructured":"Hirobata T, Inaba H, Kaido Y, Kosugi D, Itoh S, Matsuoka T, et al. Serum ketone body measurement in patients with diabetic ketoacidosis. Diabetol Int. 2022;13(4):624\u201330.","journal-title":"Diabetol Int"},{"issue":"5","key":"1176_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S2213-8587(17)30093-1","volume":"5","author":"KK Dhatariya","year":"2017","unstructured":"Dhatariya KK, Umpierrez GE. Guidelines for management of diabetic ketoacidosis: time to revise? Lancet Diabetes Endocrinol. 2017;5(5):321\u20133.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1176_CR11","unstructured":"Diabetes (type. 1 and type 2) in children and young people: diagnosis and management.: National Institute for Health and Care Excellence guidance 2021. Contract No.: NG18."},{"issue":"5866","key":"1176_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/bmj.2.5866.578","volume":"2","author":"JF Munro","year":"1973","unstructured":"Munro JF, Campbell IW, McCuish AC, Duncan LJ. Euglycaemic diabetic ketoacidosis. Br Med J. 1973;2(5866):578\u201380.","journal-title":"Br Med J"},{"issue":"1","key":"1176_CR13","doi-asserted-by":"publisher","first-page":"e00300","DOI":"10.1002\/edm2.300","volume":"5","author":"A Soto-Mota","year":"2022","unstructured":"Soto-Mota A, Norwitz NG, Evans RD, Clarke K. Exogenous d-beta-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis. Endocrinol Diabetes Metab. 2022;5(1):e00300.","journal-title":"Endocrinol Diabetes Metab"},{"issue":"2","key":"1176_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/1932296814563351","volume":"9","author":"F Ceriotti","year":"2015","unstructured":"Ceriotti F, Kaczmarek E, Guerra E, Mastrantonio F, Lucarelli F, Valgimigli F, et al. Comparative performance assessment of point-of-care testing devices for measuring glucose and ketones at the patient bedside. J Diabetes Sci Technol. 2015;9(2):268\u201377.","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"1176_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/dme.12875","volume":"33","author":"KK Dhatariya","year":"2016","unstructured":"Dhatariya KK, Nunney I, Higgins K, Sampson MJ, Iceton G. National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014. Diabet Med. 2016;33(2):252\u201360.","journal-title":"Diabet Med"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-023-01176-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-023-01176-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-023-01176-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T13:20:06Z","timestamp":1700486406000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-023-01176-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1176"],"URL":"https:\/\/doi.org\/10.1186\/s13098-023-01176-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"3 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"King Hamad University Hospital Institutional Review Board (Reference #: 22\u2013515) approved this study; approval date May 30, 2022. All patients gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}